Literature DB >> 25408208

Lower risk of Alzheimer's disease mortality with exercise, statin, and fruit intake.

Paul T Williams1.   

Abstract

BACKGROUND: Whether lifestyle affects Alzheimer's disease (AD) risk remains controversial.
OBJECTIVE: Test whether exercise, diet, or statins affect AD mortality in 153,536 participants of the National Runners' and Walkers' Health Studies.
METHODS: Hazard ratios (HR) and 95% confidence intervals (95% CI) were obtained from Cox proportional hazard analyses for AD mortality versus baseline metabolic equivalent (MET) hours/d of exercise energy expenditure (1 MET equals approximately 1 km run), statin use, and fruit intake when adjusted for age, race, gender, education, and exercise mode.
RESULTS: The National Death Index identified 175 subjects who died with AD listed as an underlying (n = 116) or contributing (n = 59) cause of death during 11.6-year average mortality surveillance. Relative to exercising <1.07 MET-hours/d, AD mortality was 6.0% lower for 1.07 to 1.8 MET-hours/d (HR: 0.94, 95% CI: 0.59 to 1.46, p = 0.79), 24.8% lower for 1.8 to 3.6 MET-hours/d (HR: 0.75, 95% CI: 0.50 to 1.13, p = 0.17), and 40.1% lower for ≥3.6 MET-hours/d (HR: 0.60, 95% CI: 0.37 to 0.97, p = 0.04). Relative to non-use, statin use was associated with 61% lower AD mortality (HR: 0.39, 95% CI: 0.15 to 0.82, p = 0.01), whereas use of other cholesterol-lowering medications was not (HR: 0.78, 95% CI: 0.40 to 1.38, p = 0.42). Relative to <1 piece of fruit/day, consuming 2 to 3 pieces daily was associated with 39.7% lower AD mortality (HR: 0.60, 95% CI: 0.39 to 0.91, p = 0.02) and ≥3 pieces/day with 60.7% lower AD mortality (HR: 0.39, 95% CI: 0.22 to 0.67, p = 0.0004).
CONCLUSIONS: Exercise, statin, and fruit intake were associated with lower risk for AD mortality.

Entities:  

Keywords:  Alzheimer's disease; diet; epidemiology; prevention; prospective cohort study; running; statins; walking

Mesh:

Substances:

Year:  2015        PMID: 25408208     DOI: 10.3233/JAD-141929

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

1.  [Successful aging: what can neurology and geriatrics contribute?].

Authors:  M Synofzik; W Maetzler
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

2.  Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor.

Authors:  Tingting Chen; Conghui Wang; Sha Sha; Libin Zhou; Lei Chen; Ling Chen
Journal:  Mol Neurobiol       Date:  2015-07-22       Impact factor: 5.590

Review 3.  Genetic markers in biological fluids for aging-related major neurocognitive disorder.

Authors:  S A Castro-Chavira; T Fernandez; H Nicolini; S Diaz-Cintra; R A Prado-Alcala
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 4.  Moonshots for aging.

Authors:  Sandeep Kumar; Timothy R Peterson
Journal:  Nutr Healthy Aging       Date:  2020-11-03

5.  Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease.

Authors:  Xin-Kang Tong; Jessika Royea; Edith Hamel
Journal:  Cell Death Dis       Date:  2022-04-09       Impact factor: 8.469

6.  Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese.

Authors:  Xiao-Long Chang; Lin Tan; Meng-Shan Tan; Hui-Fu Wang; Chen-Chen Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-04-19

7.  The double-edged role of copper in the fate of amyloid beta in the presence of anti-oxidants.

Authors:  Jing Yang; Xueli Zhang; Yiying Zhu; Emily Lenczowski; Yanli Tian; Jian Yang; Can Zhang; Markus Hardt; Chunhua Qiao; Rudolph E Tanzi; Anna Moore; Hui Ye; Chongzhao Ran
Journal:  Chem Sci       Date:  2017-06-22       Impact factor: 9.825

8.  Statins use and risk of dementia: A dose-response meta analysis.

Authors:  Xiaoyu Zhang; Jianzhong Wen; Zhiqiang Zhang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.